Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Wildlife Conservation topic
No spam. Unsubscribe anytime.
Senate bans biomedical harvesting of horseshoe crabs amid conservation concerns
Summary
The Senate approved a ban on harvesting horseshoe crabs for biomedical purposes in New York, citing population declines and ecological impacts on migratory shorebirds; the measure drew debate over biomedical supply and alternatives.
The New York State Senate on Tuesday passed legislation banning the harvest of horseshoe crabs for biomedical purposes within the state, citing steep population declines and the species’ role in coastal ecosystems.
Supporters said the harvest threatens the animals and the shorebirds that rely on their eggs during spring migration. Senator Ryan and others described scenes of mass harvesting and urged stronger protection; advocates emphasized the red knot and other migratory shorebirds that feed on horseshoe crab eggs at Delaware Bay and along New York beaches.
Opponents asked whether a ban on in‑state biomedical uses could impede vaccine and therapeutic testing that rely on components derived from horseshoe crabs’ blood. Floor discussion referenced scientific efforts to develop synthetic alternatives and noted that other states and biomedical suppliers already source material from outside New York.
The roll call recorded 43 ayes and 16 nays; the bill passed and now goes to the governor.
Why it matters: The bill restricts a biomedical input that has been used in laboratory testing and medical-device safety tests, and it reflects a conservation‑driven approach aimed at protecting shorebirds and coastal ecosystems.
